Patents Assigned to AbAg
  • Publication number: 20100196422
    Abstract: The invention concerns novel polypeptides, or parts or variants of the novel polypeptides, the use of sequences encoding the polypeptides and the use of antibodies directed against the polypeptides in the field of in vitro diagnosis of a Staphylococcus epidermidis and/or Staphylococcus aureus infection on foreign material implanted in the body.
    Type: Application
    Filed: May 4, 2005
    Publication date: August 5, 2010
    Applicant: ABAG
    Inventor: Jean-Philippe Arie
  • Publication number: 20080260767
    Abstract: The invention relates to novel polynucleotides, including SEQ ID NO: 1 or parts or variants of the sequence, novel polypeptides encoded by the polynucleotides, expression vectors including the polynucleotides and host cells including the expression vectors. The polynucleotides and polypeptides can be used in the field of in vitro diagnosis and/or for production of vaccines against Legionella pneumophila.
    Type: Application
    Filed: June 21, 2005
    Publication date: October 23, 2008
    Applicant: ABAG
    Inventors: Jean-Philippe Arie, Camille Cyncynatus
  • Publication number: 20080206752
    Abstract: Methods and devices for attaching biomolecules to a solid substrate surface for example to the inner surface of a capillary. In particular, the invention relates to compounds and methods for creating patterned arrays of biomolecules inside fused silica capillaries so that a plurality of bioassays can be conducted simultaneously.
    Type: Application
    Filed: February 10, 2005
    Publication date: August 28, 2008
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIDQUE, AbAg
    Inventors: Maxime Balakirev, Jan Sudor, Francois Chatelain, Xavier Coqueret